Patient-reported outcomes (PROs) reflect the patient's perspective and are used in
rheumatoid arthritis (RA) routine clinical practice. Patient global assessment (PGA) is one of …

Purpose Sarcopenia is an age-related muscle condition which is frequently a precursor of
frailty, mobility disability and premature death. It has a high prevalence in older populations …

Objective To evaluate the efficacy and safety of ABT‐494, a selective JAK‐1 inhibitor, in
patients with moderate‐to‐severe rheumatoid arthritis (RA) and an inadequate response to …

Objective To investigate whether an intensive early rheumatoid arthritis (RA) treat-to-target
(T2T) strategy could be improved through the use of musculoskeletal ultrasound (MSUS) …

Objective To compare the efficacy and safety of ABT‐494, a novel selective JAK‐1 inhibitor,
with placebo in patients with moderate‐to‐severe rheumatoid arthritis (RA) and an …

Objective The integration of the patient in therapeutic decision‐making is important in the
management of rheumatoid arthritis (RA), but the patient opinion regarding disease status …

The physiological function initially attributed to the oligosaccharide moieties or glycans on
inflammatory glycoproteins was to improve protein stability. However, it is now clear that …

Background Sarilumab is a human monoclonal antibody directed against the alpha subunit
of the interleukin-6 receptor complex. In the MOBILITY phase III randomized controlled trial …

Aim In this study, efficacy, tolerability and safety of biosimilar adalimumab (Exemptia; Zydus
Cadila) was compared with reference adalimumab (Humira; AbbVie) in patients with …

Objectives To compare patient-reported outcomes (PROs) in methotrexate (MTX)-naive
patients (defined as no prior treatment or≤ 3 doses) receiving tofacitinib versus MTX …